That Ozempic (or Wegovy, the name by which the weight-loss version of the drug semaglutide is marketed) should have proliferated in an industry that has always venerated thinness will hardly come as a ...
In mid-September, Novo Nordisk inked a pair of deals worth a total of more than $1.1 billion in research and development (R&D ...
The CEO of the company that makes Olympic and Wegovy was on Capitol Hill this week—asked by senators why popular diabetes and weight loss drugs are so much pricer in the U.S. compared to other ...